메뉴 건너뛰기




Volumn 36, Issue 4, 2004, Pages 1078-1079

The impact of delayed graft function of the kidney on the pancreas allograft in simultaneous Kidney-Pancreas transplantation

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

EID: 2942657686     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.04.052     Document Type: Conference Paper
Times cited : (5)

References (4)
  • 1
    • 0032573754 scopus 로고    scopus 로고
    • Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection
    • Shoskes D.A., Cecka J.M. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation. 66:1998;1697
    • (1998) Transplantation , vol.66 , pp. 1697
    • Shoskes, D.A.1    Cecka, J.M.2
  • 2
    • 0028961964 scopus 로고
    • Delayed graft function, acute rejection, and outcome after cadaver renal transplantation: A multivariate analysis
    • Troppmann C., Gillingham K.J., Benedetti E., et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation a multivariate analysis. Transplantation. 59:1995;962
    • (1995) Transplantation , vol.59 , pp. 962
    • Troppmann, C.1    Gillingham, K.J.2    Benedetti, E.3
  • 3
    • 0036130039 scopus 로고    scopus 로고
    • The impact of delayed graft function on the long-term outcome of renal transplantation
    • Geddes C.C., Woo Y.M., Jardine A.G. The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol. 15:2002;17
    • (2002) J Nephrol , vol.15 , pp. 17
    • Geddes, C.C.1    Woo, Y.M.2    Jardine, A.G.3
  • 4
    • 0037469053 scopus 로고    scopus 로고
    • Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: Primary endpoint analysis of a multicenter, randomized study
    • Stratta R.J., Alloway R.R., Lo A., et al. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients primary endpoint analysis of a multicenter, randomized study. Transplantation. 75:2003;1260
    • (2003) Transplantation , vol.75 , pp. 1260
    • Stratta, R.J.1    Alloway, R.R.2    Lo, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.